Please vote for our app, so more patients can benefit!

22 Jun 2017, 12:31 p.m.

Blood Quest app

Our app Blood Quest is a finalist in two categories of the AbilityNet Tech4Good Awards, which recognise organisations and individuals using technology for real, tangible good. “With the help of the right people, technology can really help change people’s lives,” said Mark Walker, the Tech4Good Awards' Organiser.

Blood Quest is a free, beautifully illustrated iPad app we created to inform, entertain and distract patients while they’re having their blood taken, helping them to prepare for the test and alleviating anxiety. They can play the ‘quest’ game with different levels to complete, and answer quizzes about animals and their hearts. Each level lasts the length of an average blood test, and is designed to occupy the young person specifically during the procedure.

As well as the Digital Health award, which is voted for by judges, we have been nominated for the People’s Award, decided by the public, which is where YOU can help!

We need to harness as much support as possible via our webpage and hashtag before voting closes on at 5pm on Friday 7 July. Voting is a free opportunity to spread the word about the app far and wide, so more patients can benefit from using it.

To vote, please retweet this tweet, or post your own message on Twitter or Instagram and include our unique hashtag #T4GBloodQuest. You can also vote on the Tech4Good site. Thanks for your support!

Vote for us on the Tech4Good site!

Vote for us on the Tech4Good site!

New research analyses key immune cell

A new study led by researchers at University College London Great Ormond Street Institute of Child Health has found that women have a higher proportion of key immune cells between puberty and menopause.

Say thank you to a nurse that's helped you

The DAISY Award is an international recognition programme that honours and celebrates the incredible work of nurses and midwives. You can nominate a registered nurse for three different categories - here's how.

First patient treated with groundbreaking gene therapy trial

A baby boy born with a rare condition has become the first in the world to be treated with a new, potentially lifechanging, investigational gene therapy on a clinical trial at Great Ormond Street Hospital (GOSH).

Professor Darren Hargrave appointed NIHR Senior Investigator

We’re delighted to announce that Professor Darren Hargrave has been named as a NIHR Senior Investigator in this year’s prestigious awards list.